A
Aion Therapeutic Inc
CNSX:AION
Aion Therapeutic Inc
CNSX:AION
Price:
0.005
CAD
Market Cap:
CA$2.4m
Relative Value
There is not enough data to reliably calculate the relative value of AION.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AION
Relative Value
Base Case
Not Available
Multiples Across Competitors
AION Competitors Multiples
Aion Therapeutic Inc Competitors
Aion Therapeutic Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Aion Therapeutic Inc
CNSX:AION
|
2.4m CAD | 0 | -9.1 | -3.5 | -3.4 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
228.5B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97.2B ZAR | 5.6 | 10.4 | 14.2 | 14.2 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.2B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
40.8B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.4B EUR | 1 | 164.3 | 29.8 | 62.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.7B USD | 12.4 | -2 737.6 | -3 585.5 | -576.1 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
28.4B ZAR | 5.3 | 6.6 | 17 | 17 | |
| ZA |
F
|
Fortress Real Estate Investments Ltd
JSE:FFB
|
27.7B ZAR | 4.6 | 10.3 | 12.2 | 12.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
